Do you need to taper off prednisone (corticosteroid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

You should taper off prednisone rather than stopping it abruptly to minimize the risk of withdrawal symptoms and maintain disease control. The most recent and highest quality study, 1, published in 2019, recommends minimizing daily doses of prednisone to ≤7.5 mg/day or discontinuing them due to the detrimental effects of long-term glucocorticoid therapy.

Tapering Schedule

A typical tapering schedule involves reducing the dose of prednisone by 5 mg every week until 10 mg/day are achieved, and then further reduction by 2.5 mg/week can be considered up to 5 mg daily, as suggested by 1. However, the tapering schedule may vary depending on the individual patient's response and medical situation.

Monitoring and Coordination

It is essential to monitor yourself for withdrawal symptoms, such as headaches, dizziness, nausea, and mood disturbances, during the tapering process and contact your healthcare provider if they become severe. Coordination with your doctor is crucial to determine the best tapering schedule for your specific medical situation.

Disease Control and Treatment

The goal of tapering prednisone is to maintain disease control while minimizing the risk of withdrawal symptoms and long-term glucocorticoid therapy side effects. Other treatment options, such as azathioprine, may be considered in combination with prednisone to reduce the occurrence of corticosteroid-related side effects, as recommended by 1.

Key Considerations

  • Minimize daily doses of prednisone to ≤7.5 mg/day or discontinue them due to the detrimental effects of long-term glucocorticoid therapy 1
  • Reduce prednisone dose by 5 mg every week until 10 mg/day are achieved, and then further reduction by 2.5 mg/week can be considered up to 5 mg daily 1
  • Monitor for withdrawal symptoms and coordinate with your doctor to determine the best tapering schedule for your specific medical situation.

From the FDA Drug Label

If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly Adrenocortical insufficiency may result from too rapid withdrawal of corticosteroids and may be minimized by gradual reduction of dosage

Yes, you need to taper off prednisone.

  • The FDA drug label recommends gradual withdrawal of the drug after long-term therapy to minimize the risk of adrenocortical insufficiency 2.
  • Abrupt withdrawal of therapy should be avoided 2.
  • Gradual reduction of dosage is necessary to prevent corticosteroid insufficiency after withdrawal of treatment 2.

From the Research

Tapering Off Ingress

  • The question of whether to taper off ingress is not directly addressed in the provided studies, as they focus on psychiatric drugs, antidepressants, benzodiazepines, and corticosteroids.
  • However, the concept of tapering off is relevant in the context of discontinuing psychiatric drugs, as discussed in the study 3.
  • This study suggests that tapering off psychiatric drugs is a highly accepted clinical approach to prevent withdrawal symptoms, and different strategies for tapering are available, including linear tapering, hyperbolic tapering, extended dosing, and substitution for a long half-life drug.
  • The study 3 also highlights the importance of guidelines in supporting patients and prescribers in achieving effective drug discontinuation, but notes that the lack of standardization among guidelines can make it difficult to reduce or stop the drug safely.

Relevance to Ingress

  • There is no direct evidence in the provided studies to suggest that ingress requires tapering off, as the studies focus on different types of medications and their discontinuation strategies.
  • However, the general principle of tapering off medications to prevent withdrawal symptoms or adverse effects may be applicable to other types of drugs, including ingress, depending on their pharmacological properties and clinical use.
  • Further studies would be needed to determine the specific requirements for tapering off ingress, if applicable, and to develop evidence-based guidelines for its safe discontinuation 3, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antidepressants plus benzodiazepines for adults with major depression.

The Cochrane database of systematic reviews, 2019

Research

Antidepressant and benzodiazepine for major depression.

The Cochrane database of systematic reviews, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.